Reuters logo
BRIEF-Sanochemia Pharmazeutika successful phase I study results for Tolperisone
November 9, 2017 / 12:42 PM / a month ago

BRIEF-Sanochemia Pharmazeutika successful phase I study results for Tolperisone

Nov 9 (Reuters) - SANOCHEMIA PHARMAZEUTIKA AG:

* SUCCESSFUL PHASE I STUDY RESULTS CONFIRM THE NON-SEDATING SIDE EFFECT OF TOLPERISONE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below